Maintenance dosing – for weight management

Maintenance dosing – for weight management

Maintenance dosing for weight management in GLP-1 medications refers to the ongoing dose a person takes after completing the initial titration (dose escalation) phase. The goal of this phase is to find the lowest effective dose that continues to support weight loss and maintain the results. Maintenance dosing typically starts after several weeks of gradually increasing the dose to minimize side effects like nausea

For most GLP-1 medications, including Semaglutide and Tirzepatide, the maintenance dose is individualized, but common doses are around 2.4 mg weekly for Semaglutide and up to 15 mg weekly for Tirzepatide. Your healthcare provider will adjust the dose based on how well the medication is working and how well you tolerate it. Regular monitoring is important to ensure continued effectiveness in weight management.